SOD1 and amyotrophic lateral sclerosis: MNs from FUS ALS iPSCs, TDP-43 ALS iPSCs and non-SOD1 FALS were used to ultimately identify a compound named ropinirole (ROPI) as a potential candidate for the ALS treatment [121].